Midatech Pharma PLC (MTPH) Sets New 52-Week Low at $77.50
Shares of Midatech Pharma PLC (LON:MTPH) hit a new 52-week low during trading on Tuesday . The stock traded as low as GBX 77.50 ($1.04) and last traded at GBX 77.50 ($1.04), with a volume of 3,000 shares. The stock had previously closed at GBX 81.50 ($1.10).
Several brokerages recently commented on MTPH. N+1 Singer reaffirmed a “buy” rating and set a GBX 140 ($1.89) price objective on shares of Midatech Pharma PLC in a research note on Monday, May 22nd. Panmure Gordon reaffirmed a “buy” rating and set a GBX 297 ($4.00) price objective on shares of Midatech Pharma PLC in a research note on Monday, May 22nd.
The company has a 50 day moving average of GBX 94.82 and a 200 day moving average of GBX 107.78. The firm’s market cap is GBX 37.74 million.
ILLEGAL ACTIVITY NOTICE: This story was first posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark laws. The correct version of this story can be accessed at https://theolympiareport.com/2017/09/19/midatech-pharma-plc-mtph-sets-new-52-week-low-at-77-50.html.
About Midatech Pharma PLC
Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company’s segments include Pipeline Research and Development, and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms.
Receive News & Ratings for Midatech Pharma PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Midatech Pharma PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.